917 studies found for:    psoriasis
Show Display Options
Rank Status Study
1 Recruiting Photocil (Topical) for the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Interventions: Drug: Photocil for Psoriasis;   Other: Placebo - Sunscreen (SPF 2)
2 Completed
Has Results
Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs
Condition: Psoriasis Chronic
Intervention:
3 Recruiting A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Subjects and Patients With Plaque Psoriasis
Condition: Psoriasis
Interventions: Biological: GSK2831781;   Biological: Placebo
4 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Intervention: Drug: Etanercept
5 Terminated
Has Results
Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy
Condition: Moderate to Severe Psoriasis
Intervention:
6 Completed
Has Results
Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Procedure: Narrow band (310-312 nm) ultraviolet light B phototherapy;   Drug: etanercept
7 Completed
Has Results
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis Vulgaris
Interventions: Drug: Taclonex Ointment and Hydrogel Patch;   Drug: Taclonex Ointment
8 Recruiting Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Dyslipidemia
Intervention:
9 Completed
Has Results
A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe Psoriasis
Condition: Psoriasis
Intervention:
10 Completed
Has Results
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Intervention: Drug: etanercept
11 Completed
Has Results
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: CP-690,550;   Drug: Placebo/CP-690,550
12 Completed
Has Results
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: CP-690,550;   Drug: Placebo/CP-690,550
13 Completed
Has Results
Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
Condition: Moderate to Severe Plaque Psoriasis
Intervention:
14 Active, not recruiting Prevalence of Sleep Disturbances in Psoriasis
Condition: Psoriasis
Intervention:
15 Active, not recruiting Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Conditions: Psoriasis;   Psoriatic Arthritis
Interventions: Drug: Apremilast tablet/pill 30 mg;   Drug: Etanercept 50 mg;   Drug: Placebo tablet;   Drug: Placebo injection (saline)
16 Completed Peds Metabolic Syndrome in Psoriasis
Conditions: Psoriasis;   Metabolic Syndrome
Intervention:
17 Active, not recruiting Tofacitinib Ointment For Chronic Plaque Psoriasis
Conditions: Psoriasis Vulgaris;   Psoriasis
Interventions: Drug: tofacitinib ointment 20 mg/g;   Drug: tofacitinib ointment 10 mg/g;   Drug: placebo ointment (vehicle)
18 Recruiting A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Conditions: Psoriasis;   Nonalcoholic Fatty Liver Disease
Intervention:
19 Completed
Has Results
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: CP 690,550 5 mg;   Drug: CP 690,550 10 mg;   Biological: Etanercept 50 mg;   Other: Placebo
20 Completed
Has Results
Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Intervention: Biological: Adalimumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years